Calcium channel activity increased by plasma from ischemic hindlimbs of rats: Role of an endogenous no synthase inhibitor

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 4 39-4, 1996, Pages

  Jin, Jong Shiaw ^a   Wilde, Dixon W ^a   Webb, R Clinton ^a   D'Alecy, Louis G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

aortic surgery; fura 2; hypertension; intermittent claudication; protein kinase C; vascular smooth muscle

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; CALCIMYCIN; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL STIMULATING AGENT; FLUORIDE SODIUM; FURA 2; GLYCERYL TRINITRATE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; SEROTONIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HINDLIMB; HYPERTENSION; INTERMITTENT CLAUDICATION; ISCHEMIA; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029866266     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.4.h1484     Document Type: Article

References (35)

1. Abbott, W. M., J. D. Cooper, and W. G. Austen. The effect of aortic clamping and declamping on renal blood flow distribution. J. Surg. Res. 14: 385-392, 1973.
2. Attia, R. R., J. D. Murphy, M. Snider, D. G. Lappas, R. C. Darling, and E. Lowenstein. Myocardial ischemia due to infrarenal aortic cross-clamping during aortic surgery in patients with severe coronary artery disease. Circulation 53: 961-965, 1976.
3. Bergqvist, D., H. O. Håkansson, B. Lindblad, and S.-E. Bergentz. The effect of infrarenal aortic clamping and declamping on central haemodynamics and tissue blood flow in pigs: a comparison of fluid replacement between a colloid and a crystalloid. Res. Exp. Med. 185: 383-390, 1985.
4. Bruner, C. A., and R. C. Webb. Increased vascular reactivity to BAY K 8644 in genetic hypertension. Pharmacology 41: 24-35, 1990.
5. Falk, J. L., E. C. Rackow, R. Blumenberg, M. Gelfand, and I. A. Fein. Hemodynamic and metabolic effects of abdominal aortic crossclamping. Am. J. Surg. 142: 174-177, 1981.
6. 2α attenuation of aortic declamping hyperemia and hypotension. J. Surg. Res. 20: 413-419, 1976.
7. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3448, 1985.
8. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2146-H2151, 1994.
9. Herbert, J. M., J. M. Augereau, J. Gleye, and J. P. Maffrand. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993-999, 1990.
10. Hoshino, J., T. Sakamaki, T. Nakamura, M. Kobayashi, M. Kato, H. Sakamoto, T. Kurashina, A. Yagi, K. Sato, and Z. Ono. Exaggerated vascular response due to endothelial dysfunction and role of the renin-angiotensin system at early stage of renal hypertension in rats. Circ. Res. 74: 130-138, 1994.
11. Ito, A., H. Shimokawa, R. Nakaike, T. Fukai, M. Sakata, T. Takayanagi, K. Egashira, and A. Takeshita. Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. Circulation 90: 2425-2431, 1994.
12. Jin, J. S., and L. G. D'Alecy. Stimulation of endogenous nitric oxide pathway by L-arginine reduces declamp mortality and attenuates hypertension associated with aortic cross clamp induced hind limb ischemia in rats. Hypertension Dallas 26: 406-412, 1995.
13. Jin, J. S., R. C. Webb, and L. G. D'Alecy. Inhibition of vascular nitric oxide-cGMP pathway by plasma from ischemic hindlimb of rats. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H254-H261. 1995.
14. Juergens, J. L., N. W. Barker, and E. A. Hines. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 21: 188-195, 1960
15. Lou, M. F. Human muscular dystrophy: elevation of urinary dimethylarginines. Science Wash. DC 203: 668-670, 1979.
16. Malinski, T., M. Kapturczak, J. Dayharsh, and D. Bohr. Nitric oxide synthase activity in genetic hypertension. Biochem. Biophys. Res. Commun. 194: 654-658, 1993.
17. Marletta, M. A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78: 927-930, 1994.
18. Mayer, B. Regulation of nitric oxide synthase and soluble guanylyl cyclase. Cell Biochem. Funct. 12: 167-177, 1994.
19. Mikkelsen, E. O., G. Costa, and N. C. B. Nyborg. Influence of endothelium on the response to calcium agonists, calcium, potassium and noradrenaline in rat aorta. Pharmacol. Toxicol. 62: 22-28, 1988.
20. Moursi, M. M., M. A. Facktor, G. B. Zelenock, and L. G. D'Alecy. Systemic hypertension induced by aortic cross-clamping: detrimental effects of direct smooth muscle relaxation compared with ganglionic blockade. J. Vasc. Surg. 19: 707-716, 1994.
21. + pump of cultured vascular smooth muscle. Hypertension Dallas 12: 32-38, 1988.
22. Overbeck, H. W., G. Wu, and J. P. Durham. Humoral factors) in hypertensive rats trophic for cultured aortic smooth muscle cells. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H767-H772, 1995.
23. Pillai, G., and M. C. Sutter. Effect of plasma from hypertensive patients on contractile response of vascular smooth muscle from normotensive rat. Can. J. Physiol. Pharmacol. 67: 1272-1277, 1989.
24. 2+ channels. Nature Lond. 303: 535-537, 1983
25. Seligman, S. P., J. P. Buyon, R. M. Clancy, B. K. Young, and S. B. Abramson. The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 171: 944-948, 1994.
26. Storm, D. S., M. B. Turla, K. M. Todd, and R. C. Webb. Calcium and contractile response to phorbol esters and the calcium channel agonists, BAY K 8644, in arteries from hypertensive rats. Am. J. Hypertens. 3: 245S-248S, 1990.
27. Storm, D. S., and R. C. Webb. Contractile responses to BAY K 8644 in rats with coarctation-induced hypertension. Proc Soc. Exp. Biol. Med. 203: 92-99, 1993.
28. Traub, O., and R. C. Webb. Angiotensin-converting enzyme inhibition during development alters calcium regulation in adult hypertensive rats. J. Pharmacol. Exp. Ther. 267: 1503-1508, 1993.
29. Vyden, J. K., J. Thorner, K. Nagasawa, T. Takano, M. F. Groseth-Dittrich, R. Perlow, and H. J. C. Swan. Metabolic and cardiovascular abnormalities in patients with peripheral arterial disease. Am. Heart J. 90: 703-708, 1975.
30. Wahler, G. M., and S. J. Dollinger. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. Am. J. Physiol 268 (Cell Physiol 37): C45-C54, 1995.
31. 2+ mobilization in isolated cardiac myocytes. Anesthesiology 79: 73-82, 1993.
32. Wilde, D. W., P. B. Furspan, and J. F. Szocik. Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension Dallas 24: 739-746, 1994.
33. Wright, G. L. The vascular sensitizing character of plasma from spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 59: 1111-1116, 1981.
34. 2+ in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun 153: 1068-1075, 1988.
35. Zeng, Y. Y., C. G. Benishin, and P. K. T. Pang. Guanine nucleotide binding proteins may modulate gating of calcium channels in vascular smooth muscle. I. Studies with fluoride. J. Pharmacol. Exp. Ther. 250: 343-351, 1989.